Delivery Order SPE2DR25D7062-SPE2DR26FX0FA
Award Date 1/28/26
Potential Completion Date 2/25/26
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Celecoxib 200mg in quantities of 500 on January 23, 2026, by the Defense Logistics Agency (DLA). This firm fixed-price, competitively awarded contract has a ceiling value of $1,012.86 with an ultimate completion date of February 20, 2026. The delivery order was placed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication, valued at $1,031.41. The award, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, utilized firm fixed price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as part of its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $1,857.29 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of 4,557,114,475 units of Celecoxib 200mg in 500-count bottles. This delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to supply pharmaceuticals and medical supplies...
- The Defense Logistics Agency awarded a delivery order valued at $1,302.42 to AmerisourceBergen Drug Corp for 100 capsules of Celebrex 200 mg on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,563,043,087 units of the medication Celecoxib 200 mg Capsule, with a total ceiling value of $1,103.10. The contract is a firm fixed-price delivery order with a period of performance through December 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This delivery order, valued at $8,663.41, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for Celebrex 200 mg capsules in unit dose packaging (100 count). The contract was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, and carries no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, under its medical supply chain operations, is the funding federal agency, and performance...
- The Defense Logistics Agency awarded a $262,000 delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the drug celecoxib. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the Defense Logistics Agency from its facility in Conshohocken, Pennsylvania within the period of performance between July 7-10, 2023. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals...
- The Defense Logistics Agency awarded a $56,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 capsules of the pharmaceutical Celecoxib 200 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by September 21, 2023. No subcontractors or set aside designations were identified....
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...